Abstract: Described herein are systems and methods for wastewater heat recovery, including a system for heat recovery, the system comprising: (i) a heat exchanger that is configured to heat water with thermal energy recovered from a wastewater stream, wherein the wastewater stream is treated by a wastewater treatment system that is in fluidic communication with the heat recovery system, and (ii) a device configured to control a flow rate of wastewater in the heat recovery system based at least in part on real-time sensor data.

Abstract: Disclosed herein is an electrochemical cell comprising an electrolyte and a cathode immersed in the electrolyte, wherein the cathode comprises a two-electron oxygen reduction reaction (2e? ORR) electrocatalyst composed of a metal chalcogenide. Also disclosed are methods for production of hydrogen peroxide or preparing oxidation products of a biomass-derived feedstock with the electrochemical cells described herein.

Abstract: We disclose a pharmaceutical composition adapted for oral delivery comprising native testosterone; a treatment regimen comprising administration of the composition(s); and methods and uses for the treatment of hormone related conditions such as hypogonadism in human male, female and transgender subjects.

Abstract: Synchronizing a pulse position modulation (PPM) signal. A method includes performing a first synchronization operation by receiving a first series of symbols. The symbols in the first series are transmitted with a pulse in a known slot, such that the symbols comprise pulses that are substantially equally spaced in time from adjacent symbols. The first synchronization operation includes identifying when each pulse is received for each of the symbols and using information identifying when each pulse is received for each of the symbols in the first series of symbols to identify symbol and slot boundaries for the pulse position modulation signal. The method further includes performing a second synchronization operation by receiving a second series of symbols transmitted in a known pattern, and identifying the known pattern in the received second series of symbols to identify a frame boundary.

Abstract: The disclosure relates to long acting parathyroid or parathyroid hormone like fusion polypeptides comprising a receptor polypeptide and its use in the treatment of hypoparathyroidism and osteoporosis.

Abstract: A feeding system for a domesticated animal such as a dog or cat comprises a vessel, such as a bowl, where the vessel has an open top end, a closed bottom end, an outer wall upstanding from the bottom end defining substantially the periphery of the vessel, and an inner wall upstanding from the said bottom end forming an inner walled compartment or area, wherein the space between the outer and inner walls defines a channel. The inner walled area and channel form two segmented and separate compartments or stations for feeding and/or hydrating an animal such as a dog or cat.

Abstract: The disclosure relates to long acting parathyroid or parathyroid hormone like fusion polypeptides comprising a receptor polypeptide and its use in the treatment of hypoparathyroidism and osteoporosis.

Abstract: Methods and systems adapted for providing forward error correction for data packets containing a relationship between the data in each data packet. Data packets encoded in one error correction coding scheme are received and a second error correction coding scheme is identified based on the relationship between the data in each data packet. The data packets are then decoded using the second error correction coding scheme.

Abstract: The disclosure relates to long acting parathyroid or parathyroid hormone like fusion polypeptides comprising a receptor polypeptide and its use in the treatment of hypoparathyroidism and osteoporosis.

Abstract: Methods and systems adapted for providing forward error correction for data packets containing a relationship between the data in each data packet. Data packets encoded in one error correction coding scheme are received and a second error correction coding scheme is identified based on the relationship between the data in each data packet. The data packets are then decoded using the second error correction coding scheme.

Abstract: The invention relates to fusion polypeptides comprising the extracellular domain of growth hormone linked either directly or indirectly to a polypeptide wherein the polypeptide is not growth hormone.

Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.

Abstract: We disclose growth hormone fusion proteins that have increased in vivo stability and activity; nucleic acid molecules encoding said proteins and methods of treatment of growth hormone related diseases that would benefit from growth hormone agonists or antagonists.

Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.

Abstract: The disclosure relates to a pharmaceutical formulation comprising hydrocortisone and its use in the treatment of conditions that would benefit from a delayed release of hydrocortisone, in particular conditions such as adrenal insufficiency, inflammatory conditions and depression.

Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.

Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to paediatric treatment regimens, the treatment of the elderly and non-human animals.

Abstract: The disclosure relates to the treatment of adrenal insufficiency with particular but not limiting application to pediatric treatment regimens, the treatment of the elderly and non-human animals.

Abstract: The disclosure relates to pharmaceutical compositions useful in the treatment of adrenal insufficiency in paediatric or elderly subjects.